• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

十六醇微球中丙戊酸和维生素E累积释放的体外评价。第2部分:抗癫痫药物。

In vitro evaluation of cumulative release of valproic acid and vitamin E from hexadecanol microspheres. Part 2: Antiepileptic agents.

作者信息

Giannola L I, De Caro V, Di Stefano V, Rizzo M C

机构信息

Dipartimento di Chimica e Technologie Farmaceutiche, Università di Palermo, Italy.

出版信息

Pharmazie. 1993 Dec;48(12):917-20.

PMID:8115437
Abstract

Hexadecanol microspheres were investigated as a vehicle for the controlled release of valproic acid. Microsphere of the antiepileptic agent were prepared by the meltable dispersion method in water using wetting agents. To prevent hepatotoxicity, microspheres containing both the drug and vitamin E were also prepared. The method in simple, inexpensive, rapid and reproducible. The drug release was evaluated in vitro. Kinetic results were analyzed to distinguish between the first-order release model and the square root of time relationship. More than 99% of the isolated microspheres were particle size range 200-710 microns. The average drug content was 24%. Drug bioavailability was greatly affected as a result of microspheres formation.

摘要

研究了十六醇微球作为丙戊酸控释载体的情况。采用可熔分散法在水中使用湿润剂制备抗癫痫药物的微球。为防止肝毒性,还制备了同时含有药物和维生素E的微球。该方法简单、廉价、快速且可重复。体外评估了药物释放情况。分析动力学结果以区分一级释放模型和时间平方根关系。超过99%的分离微球粒径范围为200 - 710微米。平均药物含量为24%。微球形成导致药物生物利用度受到很大影响。

相似文献

1
In vitro evaluation of cumulative release of valproic acid and vitamin E from hexadecanol microspheres. Part 2: Antiepileptic agents.十六醇微球中丙戊酸和维生素E累积释放的体外评价。第2部分:抗癫痫药物。
Pharmazie. 1993 Dec;48(12):917-20.
2
Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design.采用 Taguchi 设计法制备和优化丙戊酸纳米结构脂质载体。
Pharm Dev Technol. 2010 Jan-Feb;15(1):89-96. doi: 10.3109/10837450903013568.
3
White beeswax microspheres: a comparative in vitro evaluation of cumulative release of the anticancer agents fluorouracil and ftorafur.白蜂蜡微球:抗癌药物氟尿嘧啶和替加氟累积释放的体外比较评价
Pharmazie. 1993 Feb;48(2):123-6.
4
Controlled release of a highly hydrophilic API from lipid microspheres obtained by prilling: analysis of drug and water diffusion processes with X-ray-based methods.喷雾造粒法制备的亲水性 API 脂质微球的控释:基于 X 射线法的药物和水分扩散过程分析。
J Control Release. 2012 Mar 28;158(3):393-402. doi: 10.1016/j.jconrel.2011.11.027. Epub 2011 Nov 29.
5
Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.聚乳酸-羟基乙酸共聚物微球平均直径和多分散性对药物释放的影响:实验与理论
Int J Pharm. 2007 Jun 7;337(1-2):118-26. doi: 10.1016/j.ijpharm.2006.12.037. Epub 2007 Jan 7.
6
Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.载氧烯洛尔生物黏附微球:制备及体外/体内特性研究
J Microencapsul. 2003 Nov-Dec;20(6):777-89. doi: 10.1080/02652040310001599742.
7
Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.通过乳液溶剂蒸发法和乳液非溶剂添加法制备的含茶碱醋酸丁酸纤维素微球的微观性质及释放行为
Arch Pharm Res. 2009 Jul;32(7):1019-28. doi: 10.1007/s12272-009-1707-y. Epub 2009 Jul 31.
8
[Preparation of sustained-release nitrendipine microspheres with a solid dispersed structure in liquid system].[液体制备具有固体分散结构的硝苯地平缓释微球]
Yao Xue Xue Bao. 2003 Aug;38(8):634-8.
9
Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.采用乳化-溶剂扩散法制备莪术油缓释微球及其自乳化和油的生物利用度研究。
Colloids Surf B Biointerfaces. 2006 Mar 1;48(1):35-41. doi: 10.1016/j.colsurfb.2005.12.011. Epub 2006 Feb 9.
10
Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.喷雾干燥法制备的载卡马西平壳聚糖和羟丙基甲基纤维素微球:制备与表征
J Pharm Pharmacol. 2003 Jul;55(7):921-31. doi: 10.1211/0022357021503.

引用本文的文献

1
Solid and Semisolid Innovative Formulations Containing Miconazole-Loaded Solid Lipid Microparticles to Promote Drug Entrapment into the Buccal Mucosa.含有载咪康唑固体脂质微粒的固体和半固体创新制剂,以促进药物包封进入颊黏膜。
Pharmaceutics. 2021 Aug 29;13(9):1361. doi: 10.3390/pharmaceutics13091361.
2
Antibacterial PEGylated Solid Lipid Microparticles for Cosmeceutical Purpose: Formulation, Characterization, and Efficacy Evaluation.用于药妆用途的抗菌聚乙二醇化固体脂质微粒:制剂、表征及功效评估
Materials (Basel). 2020 Apr 30;13(9):2073. doi: 10.3390/ma13092073.